Global Chemical CDMO Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Chemical CDMO Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
CDMO, Contract development and manufacturing organization, is an emerging R&D and production outsourcing organization, mainly for the products of medical production enterprises and biotechnology companies, especially the process R&D and preparation of innovative products, process optimization, registration and verification batch production and commercial A service organization for customized R&D and production.
Chemical CDMO report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Chemical CDMO market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Pharmaceutical Company and Biotechnology Company are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Chemical CDMO industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Chemical CDMO key companies include Lonza, Catalent, GenScript Biotech, Biosynth, Otsuka Chemical, AGC Pharma Chemicals, Jubilant Bhartia Group, Sinopep Allsino Bio Pharmaceutical and Wuxi Biologics (Cayman), etc. Lonza, Catalent, GenScript Biotech are top 3 players and held % share in total in 2022.
Chemical CDMO can be divided into Small Molecule Preparations and Macromolecule Preparations, etc. Small Molecule Preparations is the mainstream product in the market, accounting for % share globally in 2022.
Chemical CDMO is widely used in various fields, such as Pharmaceutical Company, Biotechnology Company and Others,, etc. Pharmaceutical Company provides greatest supports to the Chemical CDMO industry development. In 2022, global % share of Chemical CDMO went into Pharmaceutical Company filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Chemical CDMO market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Lonza
Catalent
GenScript Biotech
Biosynth
Otsuka Chemical
AGC Pharma Chemicals
Jubilant Bhartia Group
Sinopep Allsino Bio Pharmaceutical
Wuxi Biologics (Cayman)
Porton Fine Chemicals
Zhejiang Jiuzhou Pharmaceutical
NYCRIST
Guangzhou Bositao Controlled Release Pharmaceutical
Charles River
Cambrex
Almac Group
Jubilant Pharmova
Cambrex
Siegfried Holding AG
Aenova Group
Samsung BioLogics
Segment by Type
Small Molecule Preparations
Macromolecule Preparations
Pharmaceutical Company
Biotechnology Company
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Chemical CDMO market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Chemical CDMO introduction, etc. Chemical CDMO Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Chemical CDMO market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Chemical CDMO report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Chemical CDMO market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Pharmaceutical Company and Biotechnology Company are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Chemical CDMO industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Chemical CDMO key companies include Lonza, Catalent, GenScript Biotech, Biosynth, Otsuka Chemical, AGC Pharma Chemicals, Jubilant Bhartia Group, Sinopep Allsino Bio Pharmaceutical and Wuxi Biologics (Cayman), etc. Lonza, Catalent, GenScript Biotech are top 3 players and held % share in total in 2022.
Chemical CDMO can be divided into Small Molecule Preparations and Macromolecule Preparations, etc. Small Molecule Preparations is the mainstream product in the market, accounting for % share globally in 2022.
Chemical CDMO is widely used in various fields, such as Pharmaceutical Company, Biotechnology Company and Others,, etc. Pharmaceutical Company provides greatest supports to the Chemical CDMO industry development. In 2022, global % share of Chemical CDMO went into Pharmaceutical Company filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Chemical CDMO market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Lonza
Catalent
GenScript Biotech
Biosynth
Otsuka Chemical
AGC Pharma Chemicals
Jubilant Bhartia Group
Sinopep Allsino Bio Pharmaceutical
Wuxi Biologics (Cayman)
Porton Fine Chemicals
Zhejiang Jiuzhou Pharmaceutical
NYCRIST
Guangzhou Bositao Controlled Release Pharmaceutical
Charles River
Cambrex
Almac Group
Jubilant Pharmova
Cambrex
Siegfried Holding AG
Aenova Group
Samsung BioLogics
Segment by Type
Small Molecule Preparations
Macromolecule Preparations
Segment by Application
Pharmaceutical Company
Biotechnology Company
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Chemical CDMO market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Chemical CDMO introduction, etc. Chemical CDMO Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Chemical CDMO market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices